ZHU:CA:TSX-BMO Equal Weight US Health Care (CAD)

COMMON STOCK | |

Last Closing

CAD 42.45

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

555.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

N/A

CAD 192.55B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.04 (-0.17%)

CAD 163.57B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

-0.02 (-0.08%)

CAD 159.30B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

+0.05 (+0.20%)

CAD 141.54B
TD-PFL:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 141.31B
ENB-PFV:CA Enbridge Inc Pref 5

N/A

CAD 111.03B
ENB-PFA:CA Enbridge Inc Pref 9

-0.03 (-0.16%)

CAD 110.83B
ENB-PFC:CA Enbridge Inc Pref 11

-0.06 (-0.34%)

CAD 105.87B
ENB-PFG:CA Enbridge Inc Pref 15

-0.10 (-0.59%)

CAD 100.26B
ENB-PFU:CA Enbridge Inc Pref L

-0.15 (-0.72%)

CAD 82.08B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.66% N/A N/A 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.66% N/A N/A 43% F
Trailing 12 Months  
Capital Gain -0.38% N/A N/A 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.38% N/A N/A 29% F
Trailing 5 Years  
Capital Gain 39.00% N/A N/A 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.00% N/A N/A 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.42% N/A N/A 68% D+
Dividend Return 7.42% N/A N/A 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.28% N/A N/A 59% D-
Risk Adjusted Return 55.85% N/A N/A 80% B-
Market Capitalization 0.05B N/A N/A 27% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike